These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7783231)

  • 1. Plasma and cerebrospinal fluid concentrations of 4-aminopyridine following intravenous injection and metered intrathecal delivery in canines.
    Pratt K; Toombs JP; Widmer WR; Borgens RB
    J Neurotrauma; 1995 Feb; 12(1):23-39. PubMed ID: 7783231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 4-aminopyridine derivatives in dogs.
    Olby NJ; Smith DT; Humphrey J; Spinapolice K; Parke N; Mehta PM; Dise D; Papich M
    J Vet Pharmacol Ther; 2009 Oct; 32(5):485-91. PubMed ID: 19754916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of 4-aminopyridine in chronic spinal injured patients.
    Halter JA; Blight AR; Donovan WH; Calvillo O
    Spinal Cord; 2000 Dec; 38(12):728-32. PubMed ID: 11175372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK.
    Zhu XG; Greeley GH; Lewis BG; Lilja P; Thompson JC
    J Neurosci Res; 1986; 15(3):393-403. PubMed ID: 3754587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for determining 4-aminopyridine in plasma: pharmacokinetics in anaesthetized guinea pigs after intravenous administration.
    Capacio BR; Byers CE; Matthews RL; Chang FC
    Biomed Chromatogr; 1996; 10(3):111-6. PubMed ID: 8792860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous infusion of 4-AP in chronic spinal cord injured subjects.
    Donovan WH; Halter JA; Graves DE; Blight AR; Calvillo O; McCann MT; Sherwood AM; Castillo T; Parsons KC; Strayer JR
    Spinal Cord; 2000 Jan; 38(1):7-15. PubMed ID: 10762192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
    Lim JH; Muguet-Chanoit AC; Smith DT; Laber E; Olby NJ
    PLoS One; 2014; 9(12):e116139. PubMed ID: 25551385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
    Blight AR; Henney HR
    Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in the dog.
    Yaksh TL; de Kater A; Dean R; Best BM; Miljanich GP
    Neuromodulation; 2012; 15(6):508-19; discussion 519. PubMed ID: 22748108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial).
    Penn RD; Kroin JS; York MM; Cedarbaum JM
    Neurosurgery; 1997 Jan; 40(1):94-9; discussion 99-100. PubMed ID: 8971830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury.
    Hayes KC; Katz MA; Devane JG; Hsieh JT; Wolfe DL; Potter PJ; Blight AR
    J Clin Pharmacol; 2003 Apr; 43(4):379-85. PubMed ID: 12723458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: a Phase I-II, open-label trial.
    Vollmer T; Henney HR
    Clin Ther; 2009 Oct; 31(10):2206-14. PubMed ID: 19922891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial.
    Blight AR; Toombs JP; Bauer MS; Widmer WR
    J Neurotrauma; 1991; 8(2):103-19. PubMed ID: 1870134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)].
    Watanabe K; Ishikawa S; Kimoto T; Nosaka K; Kajikawa H
    No Shinkei Geka; 1976 Apr; 4(4):351-8. PubMed ID: 944876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal pressure monitoring and cerebrospinal fluid drainage in acute spinal cord injury: a prospective randomized trial.
    Kwon BK; Curt A; Belanger LM; Bernardo A; Chan D; Markez JA; Gorelik S; Slobogean GP; Umedaly H; Giffin M; Nikolakis MA; Street J; Boyd MC; Paquette S; Fisher CG; Dvorak MF
    J Neurosurg Spine; 2009 Mar; 10(3):181-93. PubMed ID: 19320576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs.
    Flack SH; Bernards CM
    Anesthesiology; 2010 Jan; 112(1):165-73. PubMed ID: 19996952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal ketorolac in dogs and rats.
    Yaksh TL; Horais KA; Tozier N; Rathbun M; Richter P; Rossi S; Grafe M; Tong C; Meschter C; Cline JM; Eisenach J
    Toxicol Sci; 2004 Aug; 80(2):322-34. PubMed ID: 15141096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of continuous lumbar intrathecal infusion of leptin in rats on weight regulation.
    Yaksh TL; Scott B; LeBel CL
    Neuroscience; 2002; 110(4):703-10. PubMed ID: 11934477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients.
    Hansebout RR; Blight AR; Fawcett S; Reddy K
    J Neurotrauma; 1993; 10(1):1-18. PubMed ID: 8320728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs.
    Kochi M; Kuratsu J; Mihara Y; Takaki S; Inoue N; Sueyoshi N; Uemura S; Ushio Y
    Cancer Res; 1990 May; 50(10):3119-23. PubMed ID: 2334907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.